45 results on '"Baglin, Trevor"'
Search Results
2. Coagulation and platelet biology at the intersection of health and disease: illustrated capsules of the 11th Symposium on Hemostasis at the University of North Carolina
3. Design and characterization of an APC-specific serpin for the treatment of hemophilia
4. Differences in microbial metabolites in urine headspace of subjects with Immune Thrombocytopenia (ITP) detected by volatile organic compound (VOC) analysis and metabolomics
5. The Anticoagulation of Calf Thrombosis (ACT) Project: Results From the Randomized Controlled External Pilot Trial
6. Clinical Decision Rules and D-dimer in Venous Thromboembolism: Current controversies and future research priorities
7. A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop)
8. Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences
9. Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study
10. Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
11. The Critical Role of Hinge-Region Expulsion in the Induced-Fit Heparin Binding Mechanism of Antithrombin
12. Serpin-PC in Persons with Severe Hemophilia (PwH): Updated Results from a Multicenter Multi-Part, First-in-Human Study
13. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation
14. Crystal Structure of Monomeric Native Antithrombin Reveals a Novel Reactive Center Loop Conformation
15. Chapter 29 - Drugs and haemostasis
16. The Heparin Binding Properties of Heparin Cofactor II Suggest an Antithrombin-like Activation Mechanism
17. Allosteric Activation of Antithrombin Critically Depends upon Hinge Region Extension
18. Serpinpc in Persons with Severe Hemophilia (PwH): Updated Results from a Multi-Center, Multi-Part, First-in-Human Study
19. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
20. Targeting thrombin – rational drug design from natural mechanisms
21. Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
22. Antiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
23. Chapter 127 - Regulatory Mechanisms in Hemostasis
24. Evidence-based management of deep vein thrombosis and pulmonary embolus
25. Suppressing Thrombin Generation is Compatible With the Development of Atherosclerosis in Mice
26. Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment
27. Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant
28. Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
29. Lupus Anticoagulant Testing with Optical End Point Automation
30. Contributors
31. Chapter 29 - Drugs and haemostasis
32. Contributors
33. Allosteric activation of antithrombin is independent of charge neutralization or reversal in the heparin binding site
34. C0353 United Kingdom consensus based practical guide for the management of haemorrhage in patients receiving dabigatran
35. Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score
36. Further Evidence for an Anti-Thrombotic Role for Tumor Necrosis Factor alpha.
37. The Heparin Binding Properties of Heparin Cofactor II Suggest an Antithrombin -Like Activation Mechanism.
38. Contributors
39. IS PLATELET PHOSPHOLIPID-DEPENDENT THROMBIN GENERATION ALTERED BY ACUTE MYOCARDIAL INFARCTION OR ASPIRIN?
40. Thrombin Generation by Apoptotic Vascular Smooth Muscle Cells
41. Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
42. Atherogenic Lipoproteins Support Assembly of the Prothrombinase Complex and Thrombin Generation: Modulation by Oxidation and Vitamin E
43. Therapy-related acute nonlymphocytic leukemia with inversion of chromosome 16 and a sustained remission
44. THE EFFECT OF DELAYED ANALYSIS OR FREEZE-THAWING ON THE MEASUREMENT OF NATURAL ANTICOAGULANTS, RESISTANCE TO ACTIVATED PROTEIN C AND MARKERS OF ACTIVATION OF THE HAEMOSTATIC SYSTEM
45. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.